For Breast Cancer Patients Seeking a Natural Reconstruction, Hydrasolve® Liposuction From Andrew Technologies, Inc. Offers the First FDA-Cleared Option to Provide Your Own Fat for Transfer
5/24/2013 8:55:56 AM
More...
|
BioSense Technologies' IPhone Urinalysis Draws First FDA Inquiry of Medical Apps
5/24/2013 8:49:42 AM
More...
|
FDA Approves Roche (RHHBY)'s Blood Test to Diagnose Diabetes
5/24/2013 8:19:49 AM
More...
|
Celgene International Sárl (CELG) Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer
5/23/2013 11:08:54 AM
More...
|
Repros Therapeutics Inc. (RPRX) Release: FDA Recommends Running Phase 2b Trial of Proellex®-V in the Treatment of Severe Menstrual Bleeding Associated With Uterine Fibroids
5/23/2013 10:02:27 AM
More...
|
Omeros Corporation (OMER) Release: Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease
5/23/2013 9:49:59 AM
More...
|
AIBioTech Receives Subcontract Award From DynPort Vaccine Company LLC, for Continued Development and FDA Approval of a Nerve Agent Prophylactic
5/23/2013 9:33:02 AM
More...
|
The Hidden Agenda Behind the FDA's New Avandia Hearings
5/23/2013 8:34:50 AM
More...
|
FDA Panel Backs Merck & Co., Inc. (MRK) Insomnia Drug Suvorexant, But at Lower Doses
5/23/2013 7:07:15 AM
More...
|
Perosphere Inc. Receives FDA IND Clearance to Initiate Clinical Investigations of the Safety and Efficacy of PER977 to Reverse the Activity of Anticoagulation Therapies Including Factor Xa- and IIa-Inhibitors
5/22/2013 11:07:24 AM
More...
|
|